Manifold Bio • High Throughput In Vivo Drug Design
manifold.bio · 930 words · saved by 2 readers
Our innovative technology combines protein barcoding and high-throughput in vivo capabilities to design drugs with more precise molecular testing.
Manifold Bio | Tissue-targeted medicines, designed in vivo MANIFOLD BIO DEMONSTRATES MILLION-SCALE EXPERIMENTAL VALIDATION OF AI-DRIVEN PROTEIN BINDER DESIGN WITH NVIDIA Skip to Main Content Organism-scale intelligence, designed in vivo Manifold Bio has built the first high-throughput in vivo discovery engine—combining massively multiplexed in vivo screening and AI-powered design to create tissue-targeted biologics while building the virtual organism. Learn More the challenge In vitro is not in vivo Even the best AI models can only optimize for the context they are trained on. In vitro assays
saved by
related reading
- AI-Powered Drug Discovery Platform | Deep Origindeeporigin.com
- Reimagining Drug Discovery Process with AI - Isomorphic Labsisomorphiclabs.com
- AlphaProteo generates novel proteins for biology and health researchdeepmind.google
- AlphaFolddeepmind.google
- Multiply Labs | Robotic Biomanufacturing Infrastructuremultiplylabs.com
- Asimov — Intelligent Designasimov.com
- Asimov — Intelligent Designasimov.com
- Protein World Model | Biohubbiohub.ai
- One-shot design of functional protein binders with BindCraftnature.com
- OCTO - Noetiknoetik.ai
- Neion Bioneionbio.com
- prompts/prompts/multi_target_binder_design_prompt.md · Anthropic/claude-protein-binder-design at mainhuggingface.co